Led · Equity · Mar 2026

SFO Technologies operates 24 manufacturing units spread across Kochi, Bangalore and Pune, offering end-to-end EMS capabilities from product design through final assembly. The company has cultivated decades-long relationships with several Fortune 500 clients that rely on it for high-complexity, quality-driven manufacturing. With India’s EMS market growing as global supply chains diversify, SFO plans to use fresh capital to significantly expand its manufacturing capacity over the next two years, pursue backward integration into components manufacturing, and deepen its international footprint. Management emphasizes a customer-first approach, strong engineering expertise and the ability to meet stringent qualification standards as key competitive advantages. Founder N. Jehangir envisions transforming SFO into a truly global EMS leader by scaling capacity and broadening technological capabilities. No financial performance metrics such as revenue or profitability were disclosed in the article.

Participated · Equity · Oct 2023

Aequs is a diversified contract manufacturing company that began in the aerospace segment and has since expanded into consumer electronics, plastics, and cookware/small home appliances. Its customer roster includes major aerospace OEMs such as Airbus, Boeing, Bombardier, Collins Aerospace, Spirit AeroSystems, Safran, GKN Aerospace, and Honeywell, alongside consumer-sector clients like Hasbro, Spinmaster, Wonderchef, and Tramontina. The firm operates three manufacturing clusters in Karnataka (Belagavi, Hubballi, and Koppal) as well as additional plants in France and the USA. Founded by Aravind Melligeri (co-founder of QuEST Global Engineering), Aequs is backed by Amicus Capital, Amansa Capital, Steadview Capital, Catamaran, and Sparta Group. Ahead of its planned IPO, the company executed a ₹144 crore pre-IPO placement that values the new shares at ₹123.97 apiece and represents 1.88 % of equity. IPO proceeds are earmarked for debt repayment, machinery purchases for Aequs and subsidiary AeroStructures Manufacturing India, and growth initiatives including acquisitions. The IPO draft papers originally targeted a ₹720 crore fresh issue, but this has been trimmed to about ₹576 crore after the pre-IPO raise.

Led · Series B · Aug 2021

Pickrr provides an end-to-end, plug-and-play logistics solution that helps e-commerce sellers and D2C brands ship products across India and internationally. The platform offers one-click integrations with partners such as Amazon, Shopify, and WooCommerce and aggregates courier selection, pricing, and data analytics. Pickrr reports about 25 delivery partners on board and capability to ship to 29,000+ PIN codes and 220 global destinations. The company plans to continue product development and R&D and to expand its network of fulfillment centers across the country. Its services target SMBs, marketplace sellers, retailers, and D2C brands to improve delivery performance and inventory management. Pickrr Technologies is a Delhi-based, end-to-end plug-n-play logistics solution founded in 2015 that serves e-commerce sellers and D2C brands across India. Its core product is a logistics platform that routes shipments to courier partners using CALCULA, a machine-learning algorithm with 20+ proprietary logistics features that recommends couriers to improve delivery performance. The company says it will use new capital to continue market expansion and product development. Pickrr claims coverage of 26,000 pin-codes and handles 1.5 million shipments per month. The platform targets sellers and D2C brands that want to ship anything anywhere in India, emphasizing reduced delivery time and lower operational hassle. Founders named in the article are Rhitiman Majumder, Gaurav Mangla, and Ankit Kaushik.

Led · Series B · Sep 2020

Launched in 2016 and operated by Pep Technologies Pvt. Ltd., mCaffeine is focused on millennial lifestyle personal care with mass-premium caffeine-infused offerings across face, hair, body and lip categories. The brand emphasizes vegan, cruelty-free, SLS- and paraben-free formulations and claims best-sellers on Amazon and Nykaa. It is present in more than 5,000 offline stores across India and has expanded globally to three countries. mCaffeine plans to expand into about 12 international markets including GCC countries (Saudi Arabia, UAE, Qatar, Bahrain, Oman, Kuwait), parts of Europe and the United States, and to adapt formulations for regional needs. Management says the company will scale R&D, strengthen brand awareness, and fortify marketing and distribution (online and offline). The team also intends to pursue acquisitions of small beauty brands to broaden its footprint. mCaffeine is a digital-first, Mumbai-based personal-care brand built around caffeine as the primary ingredient across face, hair, and body care. The company currently offers about 20 products formulated after extensive R&D and clinical/dermatological testing and manufactures its products in India. Over four years it has sold more than 2.8 million products, amounting to Rs. 100 crores, and has bounced back from COVID-19 disruptions to surpass its pre-COVID revenue run rate. Products are available across 18,000 pin codes and on its own e-commerce site as well as Amazon, Nykaa, and Flipkart. The company plans to scale up R&D significantly, expand digital and offline distribution, grow operations and brand building, and launch 15–20 new products in the next year. mCaffeine is a Bombay-based personal care brand founded in 2016 by Vikas Lachhwani and Tarun Sharma that positions itself as India’s first caffeinated skin and hair care company. It currently sells close to 10 products and reports having served more than half a million customers. The startup distributes through its own e-commerce portal and major marketplaces including Amazon, Nykaa, and Flipkart, and is available across 18,000 pin codes. The company plans to use the new funding to grow its online and offline presence and to invest in research and product development. mCaffeine intends to expand its portfolio by about 30 products in the next 12 months and is targeting one million customers and a ₹100 crore annual revenue run rate by 2020. The brand emphasizes a mass-premium, customer-driven approach aimed at young millennials in India.

Participated · Seed · Feb 2019

Zone7 is an AI-driven human performance platform that analyzes disparate datasets, uncovers patterns, and provides proactive recommendations to improve output, detect burnout risk, and mitigate injuries. The device-agnostic platform has an extensive client portfolio in professional sports and is used across the EPL, MLS, NFL, La Liga, Serie A, PRO14 and Premiership Rugby, among other leagues. Its technology is also applied in hospitals for healthcare workforce management. Over the past year the company quadrupled its number of professional sports clients across the U.S. and Europe, developed new partnerships in contact sports and cycling, and expanded into more healthcare settings. Zone7 has made strategic hires to support priorities including service delivery within soccer and maintains offices in Palo Alto, Tel Aviv and London. Led by CEO Tal Brown, the company raised an $8M Series A to support continued client growth and partnerships. Zone7 uses pattern recognition and AI applied to athletes’ past performance and medical history to identify injury risk and recommend when players should rest. Teams in MLB, La Liga, the Champions League, MLS, collegiate athletic departments and Olympic teams are using the company's technology. The company reports a 95 percent accuracy rate in predicting injuries and says it has reduced potential injuries by 75 percent, according to a statement. Founded by Tal Brown and Eyal Eliakim, both veterans of Israel's military technology unit 8200, Zone7's executive team also has experience developing Salesforce's Einstein product and working with professional soccer franchises in Israel. Zone7 raised $2.5 million in seed funding from investors including Resolute Ventures, UpWest, Amicus Capital, Dave Pell, PLG Ventures and NBA star Kristaps Porzingis. The product emphasizes personalized intervention plans to prevent injuries before they occur.